BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Mesoblast Limited Chief Executive Honoured at the Vatican With Inaugural Pontifical Award for Innovation


4/12/2013 10:48:54 AM

MELBOURNE, Australia; 12 April 2013: Regenerative medicine company Mesoblast Limited (ASX:MSB, USOTC:MBLTY) is pleased to announce that its Chief Executive Professor Silviu Itescu today received the inaugural ‘Key Innovation Award 2013’ from the Pontifical Council for Culture and The Stem for Life Foundation. This unique recognition was announced during the Second International Vatican Adult Stem Cell Conference currently being held in Vatican City.

View the Multimedia News Release, including broadcast quality footage and images, here: http://medianet.multimediarelease.com.au/bundles/b7966695-4483-4d63-9a39-6892622f8316

The award was presented by Monsignor Tomasz Trafny, Head of the Science and Faith Department at the Pontifical Council for Culture, and Dr Robin Smith, President for the Stem for Life Foundation. Dr Smith said the award was being given “with admiration of Professor Itescu’s leadership and ingenuity in translational science and clinical medicine within the field of adult stem cell therapy.

“In every emerging industry, there are always individuals who stand out as pioneers. Professor Itescu has distinguished himself as an innovator in the field of regenerative medicine, one that has brought hope and healing to a world struggling to manage chronic disease and serious medical conditions.”

“I am honoured to have received such a distinguished award", Professor Itescu said. "It signifies important recognition of the contributions made by the dedicated team at Mesoblast striving to deliver safe and effective new therapies at the forefront of regenerative medicine”.

Mesoblast's achievements using its allogeneic adult stem cell technology platform in various conditions, including cardiovascular diseases will be highlighted at the conference by Dr Emerson C. Perin, Director, Clinical Research for Cardiovascular Medicine and Medical Director, Stem Cell Center, Texas Heart Institute, and Mesoblast's Chief Medical Officer, Dr Donna Skerrett.

The Second International Vatican Adult Stem Cell Conference, entitled Regenerative Medicine: a Fundamental Shift in Science & Culture, is being held within The Vatican, from 11-13 April 2013. The event is part of a five-year collaboration between The Vatican’s Pontifical Council for Culture and its Foundation, called STOQ International (Science, Theology and the Ontological Quest), The Stem for Life Foundation, a not-for-profit organization devoted to raising global awareness of the therapeutic potential of adult stem cells, and NeoStem Inc.

Mesoblast Limited

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including cardiovascular disorders, inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney disease, and orthopedic spine conditions. www.mesoblast.com

For further information, please contact:

Julie Meldrum

Global Head of Corporate Communications

T: + 61 3 9639 6036

M: +61 419 228 128

E: julie.meldrum@mesoblast.com

College Hill

Melanie Toyne Sewell / Gemma Howe

T: +44 20 7457 2020

E: Mesoblast@collegehill.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->